Skip to main content
. 2016 Jun 27;8(25):40152–40168. doi: 10.18632/oncotarget.10308

Table 2. Deregulated DNA repair pathways between Olaparib sensitive and resistant cell lines.

Cell line DNA repair ingenuity canonical pathways p-value Upregulated genes Downregulated genes
OV2295 NHEJ 0.0035 DCLRE1C, LIG4
OV4453 MMR 0.045 RPA1 EXO1
TOV1946 MMR 5.25e-10 MLH1, FEN1, RFC3, EXO1, POLD1, PCNA, RFC1, RFC5, MSH6, RFC4, MSH2
HR 4.68e-07 BRCA1, POLA1, RAD50, ATM, RPA1, LIG1, RAD51, ATRX, MRE11A, NBN
NHEJ 6.92e-06 PARP1, RAD50, XRCC5, ATM, XRCC4, DCLRE1C, MRE11A, LIG4, NBN
TOV3041G HR 8.51e-06 LIG1, RAD51 BRCA1, RAD50, ATRX, MRE11A, NBN
NHEJ 1.15e-04 RAD50, XRCC4, DCLRE1C, MRE11A, LIG4, NBN
MMR 0.015 RFC3, MSH6, MSH2
OV1946 MMR 6.61e-10 MLH1, FEN1, RFC3, EXO1, MSH6, RFC5, POLD1, RFC4, PCNA, MSH2
HR 0.0074 RPA1, RAD51, ATRX, MRE11A, NBN
NHEJ 0.0074 PARP1, XRCC4, MRE11A, LIG4, NBN
NER 0.044 POLR2B, RPA2, POLR2J, POLR2C, POLR2I, POLR2K